Pharmacokinetics and Pharmacodynamics of Recombinant FGF‐2 in a Phase I Trial in Coronary Artery DiseaseMark Bush, Nicolas A.F. Chronos, Emil Samara et al.|The Journal of Clinical Pharmacology|2001Cited by 48
Pharmacokinetics of 2 Novel Formulations of Modified‐Release Oral Testosterone Alone and With Finasteride in Normal Men With Experimental HypogonadismC. N. Snyder, John K. Amory, Richard V. Clark et al.|Journal of Andrology|2010Cited by 10
Pharmacokinetics of Modified Slow‐Release Oral Testosterone Over 9 Days in Normal Men With Experimental HypogonadismAda Lee, John K. Amory, Hui Zhi et al.|Journal of Andrology|2012Cited by 8
Responding to the Call to Action: Framework to Accelerate Clinical Data Generation for Antiretroviral Use in Pregnant Individuals with HIVVani Vannappagari, Annemiek de Ruiter, Scott McCallister et al.|Infectious Diseases and Therapy|2024Cited by 4
Population Pharmacokinetic Modeling of Abacavir/Dolutegravir/Lamivudine to Support a Fixed-Dose Combination in Children with HIV-1Hardik Chandasana, Sven C. van Dijkman, Rashmi Mehta et al.|Infectious Diseases and Therapy|2024Cited by 3